The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-European shares fall further as mounting trade fears hit cyclicals

Fri, 23rd Mar 2018 09:51

* STOXX hits lowest in 11 months, DAX above early March low

* Cyclicals lead sectoral losers, defensives outperform

* Precious metal miners lifted by safe haven demand(For a live blog on European stocks, type LIVE/ in an Eikonnews window)

By Danilo Masoni

MILAN, March 23 (Reuters) - European shares fell on Fridaywith autos and basic resources stocks bearing the brunt of awide sell-off triggered by mounting worries that U.S. tariffs onup to $60 billion of imports from China could escalate.

All sectors were trading in negative territory, sendingpan-regional STOXX 600 benchmark index falling for asecond day, down 1.4 percent to its lowest level since February2017.

All eyes were on the response from China, which urged theUnited States on Friday to "pull back from the brink", andunveiled its own plans to impose tariffs on up to $3 billion ofU.S. imports.

Although risks that the tariffs could trigger a full-blowntrade war, some investors said they still did not expect that tohappen, highlighting that the retaliation measures announced byChina remained relatively mild.

Caution, however, pushed investors into defensive stockslike utilities and telecoms, which declined byless than 1 percent but outperformed the broader market, as theyare seen as less exposed to a deterioration in global trade.

Euro zone indexes including the export-sensitive DAXalso fell more 1.8 percent but remained above earlyMarch lows, while the FTSE dropped 1.1 percent to fresh15-month lows reached on the back of a strengthening pound.

"Our central scenario remains one in which retaliation willbe contained and will leave little impact on growth, but therisk of it happening alone is enough for us to maintain apreference for defensive assets," said UniCredit economists ledby Chiara Silvestre in a note.

Enel fell 0.2 percent after Italy's biggestutility reported growth a 14.4 percent growth in its 2017ordinary net profit last year that to beat its own guidance.

Among the few gainers on Friday were shares in metal minersFresnillo, Randgold and Polymetal ,all up between 0.5 and 1.5 percent, as the gold price rose onthe back of growing demand for safe haven assets.

Still on the tariff front, the previously announced U.S.tariffs on steel and aluminium imports will take effect onFriday but more countries, including the European Union, haveobtained a temporary exemption.

"In theory it would be a soothing news but in reality itrisks making the confrontation between the U.S and Chinaharsher," said JCI Capital fund manager Alessandro Balsotti.

Among the companies, exposed to U.S. steel and aluminiumtariffs, shares in carmakers Fiat Chrysler and BMWfell 2.5 and 2.1 percent respectively, while steeltube maker Tenaris dropped 4.1 percent andThyssenKrupp declined 2.7 percent.

Elsewhere in corporate arena, Indivior plunged 4.4percent following an U.S. court ruling against the maker ofopioid addiction treatment Suboxone. Indivior said it intendedto appeal against the ruling in favour of generic competitorAlvogen.

Among the few gainers, GSK rose 2.9 percent after itpulled out of the bidding war for Pfizer's consumer healthbusiness <PFE.N,> following in the footsteps of ReckittBenckiser earlier this week.(Reporting by Danilo MasoniEditing by Alison Williams)

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.